Q3 EPS Forecast for Dolby Laboratories Raised by Analyst

Dolby Laboratories, Inc. (NYSE:DLB - Free Report) - Analysts at Zacks Research upped their Q3 2025 earnings per share (EPS) estimates for Dolby Laboratories in a research report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the electronics maker will post earnings per share of $0.54 for the quarter, up from their prior estimate of $0.53. The consensus estimate for Dolby Laboratories' current full-year earnings is $2.94 per share. Zacks Research also issued estimates for Dolby Laboratories' Q4 2025 earnings at $0.54 EPS, Q3 2026 earnings at $0.66 EPS and Q1 2027 earnings at $0.82 EPS.

Other equities research analysts have also recently issued research reports about the stock. Barrington Research reissued an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, February 13th. Rosenblatt Securities restated a "buy" rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, January 30th. Finally, StockNews.com cut shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st.

Dolby Laboratories Price Performance

NYSE DLB traded up $0.32 on Friday, reaching $81.72. The stock had a trading volume of 488,049 shares, compared to its average volume of 488,540. The company has a market cap of $7.80 billion, a P/E ratio of 30.04 and a beta of 0.98. The firm has a fifty day moving average of $80.68 and a two-hundred day moving average of $76.44. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $89.66.

Remove Ads

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC grew its holdings in shares of Dolby Laboratories by 4.3% during the 3rd quarter. Geode Capital Management LLC now owns 1,538,583 shares of the electronics maker's stock valued at $117,767,000 after purchasing an additional 63,293 shares during the last quarter. Lord Abbett & CO. LLC grew its stake in shares of Dolby Laboratories by 5.8% during the third quarter. Lord Abbett & CO. LLC now owns 284,466 shares of the electronics maker's stock worth $21,771,000 after buying an additional 15,546 shares during the last quarter. Barclays PLC increased its holdings in shares of Dolby Laboratories by 80.5% during the third quarter. Barclays PLC now owns 33,230 shares of the electronics maker's stock worth $2,544,000 after buying an additional 14,825 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Dolby Laboratories by 10,441,900.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 104,420 shares of the electronics maker's stock valued at $8,123,000 after acquiring an additional 104,419 shares during the last quarter. Finally, Boston Trust Walden Corp lifted its stake in shares of Dolby Laboratories by 185.3% in the 3rd quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker's stock valued at $82,276,000 after acquiring an additional 698,283 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Insider Buying and Selling

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 40,000 shares of the company's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the completion of the sale, the executive vice president now directly owns 62,397 shares in the company, valued at $5,296,257.36. This represents a 39.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ryan Nicholson sold 7,000 shares of Dolby Laboratories stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.00. Following the completion of the transaction, the chief accounting officer now owns 29,758 shares in the company, valued at approximately $2,501,755.06. The trade was a 19.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 77,459 shares of company stock valued at $6,464,675 over the last quarter. 38.39% of the stock is owned by company insiders.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Tuesday, February 11th. Dolby Laboratories's dividend payout ratio (DPR) is presently 48.53%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.